THR-317
THR-317 is a human monoclonal antibody (mAb) targeting PLGF. THR-317 can be used in Diabetic retinopathy research[1].
Product Specifications
UNSPSC
12352203
Target
VEGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[THR-317]
References & Citations
[1]Striglia E, et al. Emerging drugs for the treatment of diabetic retinopathy. Expert Opin Emerg Drugs. 2020 Sep;25 (3) :261-271.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
